NKX1-1

RNA & survival
SurvivalRNAKaplan–Meier · TCGA cohorts

Across TCGA pan-cancer cohorts, NKX1-1 RNA is linked to patient survival in 11 of 34 cancer types, making it the most broadly survival-associated NKX1-1 data layer.

The strongest signal is observed in adrenocortical carcinoma (ACC), where higher NKX1-1 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated NKX1-1 expression acts as an unfavorable survival marker.

ACC, UCS, and KICH are the cancer types where NKX1-1 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.
LineageMeasureSplitStageAUC1
high
AUC2
low
pSampling consensus
ACCOSTertileAll0.1160.706<.00172view →
UCSOSTertileIII,IV0.1040.591.00472view →
KICHDFSTertileII,III,IV0.0350.860<.00163view →
STADDFSTertileIII,IV0.4400.618.01545view →
CESCOSTertileIV0.1210.591.02936view →
LIHCDFSTertileAll0.2200.465.00233view →
BLCAOSTertileIV0.0820.575.00218view →
KIRCDFSTertileIV0.2430.642.01218view →
SARCOSTertileAll0.2420.632<.00118view →
SKCMOSTertileIV0.4150.861.0149view →
COADOSTertileAll0.3290.595.0259view →
Pink = unfavorable, green = favorable. Showing the 11 strongest of 11 lineages.

NKX1-1–ACC (OS)

Kaplan–Meier survival curve for NKX1-1 RNA-high vs -low samples in ACC.

Open the ACC breakdown →

Exploration